EDAG Engineering Group AG (ED4)
XETRA Stock Exchange · Germany · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 2.920 |
|---|---|
| 52-week range | 2.650 – 7.040 |
| Return, 1 month / 3 months | −3.9% / −6.4% |
| Return, 1 year / 3 years | −58.4% / −75.2% |
| Trend | Below its 200-day average |
| RSI (14) | 42 |
| Volatility (1 year) | 37.8% |
| Worst drawdown (1 year) | -59.7% |
| Average daily value traded | 0.01M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
EDAG Engineering Group is a German engineering services company that works mainly for the automotive industry. It develops vehicle bodies, chassis and complete vehicles for carmakers, and it plans and supports the production processes and tooling that manufacturers use to build them. The company also provides engineering services for sectors beyond cars, such as commercial vehicles and industrial equipment, and it is based in Germany with operations in several countries.
The shares are listed on the XETRA Stock Exchange in Germany under the code ED4, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
EDAG Engineering Group AG (ED4) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 2.920 on 19 October 2026.
Its price-based Market X-Ray is 20 out of 100 (a weak price profile), ranking 621 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 58.4% and over the last three months it fell 6.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 16 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -15.5% | ||
| From 52-week high | -58.3% | ||
| Momentum | 20 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -6.4% | ||
| 6-month return | -24.9% | ||
| 12-month return, skipping the last month | -56.7% | ||
| Stability (higher is calmer) | 28 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 37.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -59.7% | ||
| Liquidity | 16 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −5.5% |
|---|---|
| 1 month | −3.9% |
| 3 months | −6.4% |
| 6 months | −24.9% |
| 1 year | −58.4% |
| 3 years | −75.2% |
| 5 years | −71.8% |
Signals
| 50-day / 200-day average | 3.041 / 3.456 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.082 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Jun 2024 | CHF 0.5500 |
| 29 Jun 2023 | CHF 0.5500 |
| 24 Jun 2022 | CHF 0.2000 |
| 6 Jun 2019 | CHF 0.7500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.